Edition:
United Kingdom

Drug Retailers

Page 1

Express Scripts Holding Sees FY 2017 ADJ SHR $7.00 To $7.08

12:30pm GMT

Dec 14 (Reuters) - Express Scripts Holding Co ::EXPRESS SCRIPTS HOLDING COMPANY UPDATES 2017 FULL-YEAR GUIDANCE AND ANNOUNCES 2018 FINANCIAL GUIDANCE.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $7.67 TO $7.87.SEES FY 2017 ADJUSTED EARNINGS PER SHARE $7.00 TO $7.08.EXPECTS 2017 FULL-YEAR TOTAL ADJUSTED CLAIMS FOR ITS CORE BUSINESS TO BE IN RANGE OF 1,158 MILLION TO 1,172 MILLION.NARROWED PREVIOUSLY ISSUED CONSOLIDATED 2017 ADJUSTED EBITDA GUIDANCE TO A RANGE OF $7,370 MILLION TO $7,450 MILLION.ESTIMATE THAT EVICORE ACQUISITION WILL GENERATE EBITDA OF $265 MILLION TO $285 MILLION IN 2018.EVICORE ACQUISITION AND SALE OF UNITED BIOSOURCE ARE EXPECTED TO BE COMPLETED IN DECEMBER 2017.ENTERPRISE VALUE INITIATIVE ESTIMATED TO COST ABOUT $600-$650 MILLION & TO DELIVER CUMULATIVE SAVINGS OF NEARLY $1.2 BILLION BY 2021.FY2017 EARNINGS PER SHARE VIEW $7.01 -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $7.65 -- THOMSON REUTERS I/B/E/S.SEES CORE ESTIMATED REVENUE FOR 2018 OF $80,500 MILLION TO $83,000 MILLION.SEES CONSOLIDATED ESTIMATED REVENUE FOR 2018 OF $99,000 MILLION TO $102,000 MILLION.FY2018 REVENUE VIEW $101.29 BILLION -- THOMSON REUTERS I/B/E/S.COMPANY EXPECTS CORE 2017 FULL-YEAR ADJUSTED EBITDA GUIDANCE IN RANGE OF $4,910 MILLION TO $4,970 MILLION.SEES CORE ESTIMATED TOTAL ADJUSTED CLAIMS FOR 2018 OF 1,125 MILLION TO 1,165 MILLION.SEES CONSOLIDATED ESTIMATED TOTAL ADJUSTED CLAIMS FOR 2018 OF 1,345 MILLION TO 1,395 MILLION.

Charmacy Pharmaceutical Co's Application For Proposed A Share Offering Accepted by CSRC

11:43am GMT

Dec 14 (Reuters) - Charmacy Pharmaceutical Co Ltd <2289.HK>::CHINA SECURITIES REGULATORY COMMISSION ACCEPTED APPLICATION FOR PROPOSED A SHARE OFFERING.

Dashenlin Pharmaceutical Group to buy land for up to 150 mln yuan

10:45am GMT

Dec 14 (Reuters) - Dashenlin Pharmaceutical Group Co Ltd <603233.SS>:Says it will buy a piece of land for up to 150 million yuan .

Medical Ikkou to merge with Mie-based wholly owned unit

Wednesday, 13 Dec 2017

Dec 13 (Reuters) - Medical Ikkou Co Ltd <3353.T>:Says it will merge with Mie-based wholly owned unit, which is engaged in pharmaceuticals related business and the real estate rental business, effective March 1, 2018.Says the unit will be dissolved after merger .

Virtual Incision Announces $18 Mln Series B Funding For Miniaturized Surgical Robots

Tuesday, 12 Dec 2017

Dec 12 (Reuters) - Virtual Incision Corp::VIRTUAL INCISION ANNOUNCES $18 MILLION SERIES B FUNDING FOR MINIATURIZED SURGICAL ROBOTS.VIRTUAL INCISION CORPORATION - SERIES B FUNDING ROUND WAS CO-LED BY SINOPHARM CAPITAL & BLUESTEM CAPITAL.

Ebos Group Says CEO Patrick Davies To Step Down

Tuesday, 12 Dec 2017

Dec 13 (Reuters) - Ebos Group Ltd ::APPOINTS JOHN CULLITY AS CHIEF EXECUTIVE OFFICER .CHIEF EXECUTIVE OFFICER PATRICK DAVIES WILL STEP DOWN.

China National Medicines elects chairman

Tuesday, 12 Dec 2017

Dec 12 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS BOARD ELECTS JIANG XIUCHANG AS CHAIRMAN, REPLACING LIU YONG.

Shanghai Pharmaceuticals Holding unit receives GMP certificate

Monday, 11 Dec 2017

Dec 11 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .* Certificate issued pill and Chinese medicine extraction workshop of the unit and the valid period is until Nov. 30, 2022.

Welcia Holdings to acquire IPPONDO

Friday, 8 Dec 2017

Dec 8 (Reuters) - Welcia Holdings Co Ltd <3141.T>:Says it will fully acquire IPPONDO Co.,Ltd., which is engaged in drugstore operations, with undisclosed price, effective March 1, 2018 .

AmerisourceBergen Announces Operating Commitments to Address Opioid Diversion And Abuse

Thursday, 7 Dec 2017

Dec 7 (Reuters) - Amerisourcebergen Corp ::AMERISOURCEBERGEN ANNOUNCES OPERATING COMMITMENTS TO ADDRESS OPIOID DIVERSION AND ABUSE.AMERISOURCEBERGEN - WILL CONTINUE TO REPORT QUANTITY, RECEIVING PHARMACY OF ALL ORDERS OF OPIOID-BASED MEDICINES TO DRUG ENFORCEMENT AGENCY ON DAILY BASIS.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary